Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of bromocriptine on left ventricular function in peripartum cardiomyopathy
2007-003710-34Phase 2Completed
- Sponsor
- Medizinische Hochschule Hannover
- Start
- Jan 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of bromocriptine in Peripartum cardiomyopathy (PPCM) and Cardiomyopathies, sponsored by Medizinische Hochschule Hannover. Primary endpoints: Change in left ventricular ejection fraction by MRI and Change in left ventricular ejection fraction by echocardiography. Started Jan 2009; status: completed.
02
Drugs
bromocriptine
03
Conditions
Peripartum cardiomyopathy (PPCM)Cardiomyopathies
Beyond the preview
Go deeper on 2007-003710-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003710-34.